Phase II trial of (m-AMSA) 4'-9-(acridinylamino)-methanesulfon-m-aniside in primary liver cancer

Am J Clin Oncol. 1983 Apr;6(2):211-3. doi: 10.1097/00000421-198304000-00013.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aminoacridines / adverse effects
  • Aminoacridines / therapeutic use*
  • Amsacrine
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Hepatocellular / drug therapy*
  • Drug Evaluation
  • Humans
  • Leukopenia / chemically induced
  • Liver Neoplasms / drug therapy*
  • Middle Aged

Substances

  • Aminoacridines
  • Antineoplastic Agents
  • Amsacrine